These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 35177426)

  • 21. TSPO imaging in animal models of brain diseases.
    Van Camp N; Lavisse S; Roost P; Gubinelli F; Hillmer A; Boutin H
    Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):77-109. PubMed ID: 34245328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microglial Positron Emission Tomography Imaging In Vivo : Positron Emission Tomography Radioligands: Utility in Research and Clinical Practice.
    Ottoy J; De Picker L; Kang MS
    Adv Neurobiol; 2024; 37():579-589. PubMed ID: 39207714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET imaging of [
    Varnäs K; Cselényi Z; Jucaite A; Halldin C; Svenningsson P; Farde L; Varrone A
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):367-375. PubMed ID: 30270409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic analysis of the translocator protein positron emission tomography ligand [
    Feeney C; Scott G; Raffel J; Roberts S; Coello C; Jolly A; Searle G; Goldstone AP; Brooks DJ; Nicholas RS; Trigg W; Gunn RN; Sharp DJ
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2201-2210. PubMed ID: 27349244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal positron emission tomography imaging of glial cell activation in a mouse model of mesial temporal lobe epilepsy: Toward identification of optimal treatment windows.
    Nguyen DL; Wimberley C; Truillet C; Jego B; Caillé F; Pottier G; Boisgard R; Buvat I; Bouilleret V
    Epilepsia; 2018 Jun; 59(6):1234-1244. PubMed ID: 29672844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET imaging of translocator protein (18 kDa) in a mouse model of Alzheimer's disease using N-(2,5-dimethoxybenzyl)-2-18F-fluoro-N-(2-phenoxyphenyl)acetamide.
    James ML; Belichenko NP; Nguyen TV; Andrews LE; Ding Z; Liu H; Bodapati D; Arksey N; Shen B; Cheng Z; Wyss-Coray T; Gambhir SS; Longo FM; Chin FT
    J Nucl Med; 2015 Feb; 56(2):311-6. PubMed ID: 25613536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.
    Notter T; Coughlin JM; Gschwind T; Weber-Stadlbauer U; Wang Y; Kassiou M; Vernon AC; Benke D; Pomper MG; Sawa A; Meyer U
    Mol Psychiatry; 2018 Feb; 23(2):323-334. PubMed ID: 28093569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases.
    Dupont AC; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Tronel C; Arlicot N
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of hydroxytyrosol on stroke: tracking therapy response on neuroinflammation and cerebrovascular parameters using PET-MR imaging and on functional outcomes.
    Barca C; Wiesmann M; Calahorra J; Wachsmuth L; Döring C; Foray C; Heiradi A; Hermann S; Peinado MÁ; Siles E; Faber C; Schäfers M; Kiliaan AJ; Jacobs AH; Zinnhardt B
    Theranostics; 2021; 11(9):4030-4049. PubMed ID: 33754046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET.
    Vicidomini C; Panico M; Greco A; Gargiulo S; Coda AR; Zannetti A; Gramanzini M; Roviello GN; Quarantelli M; Alfano B; Tavitian B; Dollé F; Salvatore M; Brunetti A; Pappatà S
    Nucl Med Biol; 2015 Mar; 42(3):309-16. PubMed ID: 25537727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent developments on PET radiotracers for TSPO and their applications in neuroimaging.
    Zhang L; Hu K; Shao T; Hou L; Zhang S; Ye W; Josephson L; Meyer JH; Zhang MR; Vasdev N; Wang J; Xu H; Wang L; Liang SH
    Acta Pharm Sin B; 2021 Feb; 11(2):373-393. PubMed ID: 33643818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31.
    Simmons DA; James ML; Belichenko NP; Semaan S; Condon C; Kuan J; Shuhendler AJ; Miao Z; Chin FT; Longo FM
    Hum Mol Genet; 2018 Aug; 27(16):2893-2912. PubMed ID: 29860333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of
    Lepelletier FX; Vandesquille M; Asselin MC; Prenant C; Robinson AC; Mann DMA; Green M; Barnett E; Banister SD; Mottinelli M; Mesangeau C; McCurdy CR; Fricke IB; Jacobs AH; Kassiou M; Boutin H
    Theranostics; 2020; 10(18):7938-7955. PubMed ID: 32724451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases.
    Biechele G; Franzmeier N; Blume T; Ewers M; Luque JM; Eckenweber F; Sacher C; Beyer L; Ruch-Rubinstein F; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Cumming P; Bartenstein P; Rominger A; Höglinger GU; Herms J; Brendel M
    J Neuroinflammation; 2020 Dec; 17(1):374. PubMed ID: 33317543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The methodology of TSPO imaging with positron emission tomography.
    Turkheimer FE; Rizzo G; Bloomfield PS; Howes O; Zanotti-Fregonara P; Bertoldo A; Veronese M
    Biochem Soc Trans; 2015 Aug; 43(4):586-92. PubMed ID: 26551697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of Alzheimer's disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein.
    Ji B; Ono M; Yamasaki T; Fujinaga M; Zhang MR; Seki C; Aoki I; Kito S; Sawada M; Suhara T; Sahara N; Higuchi M
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):2076-2089. PubMed ID: 33557690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging of translocator protein upregulation is selective for pro-inflammatory polarized astrocytes and microglia.
    Pannell M; Economopoulos V; Wilson TC; Kersemans V; Isenegger PG; Larkin JR; Smart S; Gilchrist S; Gouverneur V; Sibson NR
    Glia; 2020 Feb; 68(2):280-297. PubMed ID: 31479168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TSPO PET with [
    Unterrainer M; Mahler C; Vomacka L; Lindner S; Havla J; Brendel M; Böning G; Ertl-Wagner B; Kümpfel T; Milenkovic VM; Rupprecht R; Kerschensteiner M; Bartenstein P; Albert NL
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1423-1431. PubMed ID: 29523925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease.
    Mirzaei N; Tang SP; Ashworth S; Coello C; Plisson C; Passchier J; Selvaraj V; Tyacke RJ; Nutt DJ; Sastre M
    Glia; 2016 Jun; 64(6):993-1006. PubMed ID: 26959396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study.
    Brendel M; Probst F; Jaworska A; Overhoff F; Korzhova V; Albert NL; Beck R; Lindner S; Gildehaus FJ; Baumann K; Bartenstein P; Kleinberger G; Haass C; Herms J; Rominger A
    J Nucl Med; 2016 Jun; 57(6):954-60. PubMed ID: 26912428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.